Joerg Vienken

602 total citations
29 papers, 420 citations indexed

About

Joerg Vienken is a scholar working on Nephrology, Surgery and Biomedical Engineering. According to data from OpenAlex, Joerg Vienken has authored 29 papers receiving a total of 420 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Nephrology, 6 papers in Surgery and 6 papers in Biomedical Engineering. Recurrent topics in Joerg Vienken's work include Dialysis and Renal Disease Management (8 papers), Muscle and Compartmental Disorders (3 papers) and Renal Transplantation Outcomes and Treatments (3 papers). Joerg Vienken is often cited by papers focused on Dialysis and Renal Disease Management (8 papers), Muscle and Compartmental Disorders (3 papers) and Renal Transplantation Outcomes and Treatments (3 papers). Joerg Vienken collaborates with scholars based in Germany, Italy and Israel. Joerg Vienken's co-authors include Lázaro Gotloib, Roberto Fudin, Archil Chkhotua, Pasquale Chieco, Elena Gabusi, Annalisa Altimari, Antonia D’Errico, A Yussim, Sergio Stefoni and Sudhir K. Bowry and has published in prestigious journals such as Biomaterials, American Journal of Kidney Diseases and Nephrology Dialysis Transplantation.

In The Last Decade

Joerg Vienken

29 papers receiving 405 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joerg Vienken Germany 12 155 92 71 70 67 29 420
Hyung Jong Kim South Korea 14 202 1.3× 93 1.0× 114 1.6× 53 0.8× 44 0.7× 29 478
Huiping Zhao China 13 264 1.7× 95 1.0× 139 2.0× 43 0.6× 88 1.3× 39 609
Hans von Baeyer Germany 12 144 0.9× 123 1.3× 79 1.1× 57 0.8× 56 0.8× 41 459
Katsushi Tajima Japan 11 39 0.3× 48 0.5× 70 1.0× 39 0.6× 77 1.1× 36 519
Raj Munshi United States 11 312 2.0× 124 1.3× 169 2.4× 19 0.3× 65 1.0× 25 617
Machiko Oka Japan 18 381 2.5× 350 3.8× 102 1.4× 47 0.7× 166 2.5× 58 903
A. Lehnhardt Germany 13 184 1.2× 139 1.5× 118 1.7× 25 0.4× 147 2.2× 23 559
Guo Wei United States 11 167 1.1× 84 0.9× 145 2.0× 87 1.2× 53 0.8× 24 509
L. Sereni Italy 12 242 1.6× 120 1.3× 55 0.8× 18 0.3× 36 0.5× 23 398
Charles J. Kaupke United States 14 218 1.4× 51 0.6× 47 0.7× 27 0.4× 79 1.2× 26 652

Countries citing papers authored by Joerg Vienken

Since Specialization
Citations

This map shows the geographic impact of Joerg Vienken's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joerg Vienken with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joerg Vienken more than expected).

Fields of papers citing papers by Joerg Vienken

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joerg Vienken. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joerg Vienken. The network helps show where Joerg Vienken may publish in the future.

Co-authorship network of co-authors of Joerg Vienken

This figure shows the co-authorship network connecting the top 25 collaborators of Joerg Vienken. A scholar is included among the top collaborators of Joerg Vienken based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joerg Vienken. Joerg Vienken is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Polenaković, Momir, Alı Başçı, Ljubica Djukanović, et al.. (2013). 20 years since the establishment of the BANTAO association (Balkan Cities Association of Nephrology, Dialysis, Transplantation and Artificial Organs).. PubMed. 34(2). 181–213. 3 indexed citations
2.
Vienken, Joerg. (2013). Membranes for haemodialysis. What is more important, sieving coefficient or flux?. Problemy Eksploatacji. 2 indexed citations
3.
Vienken, Joerg. (2010). Biomaterials for medical devices: Are current hemo‐ or biocompatibility tests adequate?. Materialwissenschaft und Werkstofftechnik. 41(12). 1081–1085. 3 indexed citations
4.
Shaldon, Stanley & Joerg Vienken. (2009). Beyond The Current Paradigm: Recent Advances in The Understanding of Sodium Handling – Guest Editors: Stanley Shaldon and Joerg Vienken: An Introduction. Seminars in Dialysis. 22(3). 252–252. 3 indexed citations
6.
Baurmeister, U., Joerg Vienken, & Richard Ward. (2009). PROGRESS IN UREMIC TOXIN RESEARCH: Should Dialysis Modalities be Designed to Remove Specific Uremic Toxins?. Seminars in Dialysis. 22(4). 454–457. 6 indexed citations
7.
Vienken, Joerg, et al.. (2006). How Can Liver Toxins be Removed? Filtration and Adsorption With the Prometheus System. Therapeutic Apheresis and Dialysis. 10(2). 125–131. 31 indexed citations
8.
Gotloib, Lázaro, et al.. (2005). Peritoneal dialysis in refractory end-stage congestive heart failure: a challenge facing a no-win situation. Nephrology Dialysis Transplantation. 20(suppl_7). vii32–vii36. 65 indexed citations
9.
Chkhotua, Archil, Annalisa Altimari, Elena Gabusi, et al.. (2003). Increased expression of p21(WAF1/CIP1) CDKI gene in chronic allograft nephropathy correlating with the number of acute rejection episodes. Transplantation Proceedings. 35(2). 655–658. 6 indexed citations
10.
Chkhotua, Archil, Elena Gabusi, Annalisa Altimari, et al.. (2003). Increased expression of p16(INK4a) and p27(Kip1) cyclin-dependent kinase inhibitor genes in aging human kidney and chronic allograft nephropathy. American Journal of Kidney Diseases. 41(6). 1303–1313. 96 indexed citations
11.
Chkhotua, Archil, Annalisa Altimari, Antonia D’Errico, et al.. (2003). Increased expression of p21�(WAF1/CIP1) cyclin-dependent kinase (CDK) inhibitor gene in chronic allograft nephropathy correlates with the number of acute rejection episodes. Transplant International. 16(8). 600–604. 9 indexed citations
12.
Vienken, Joerg & Sudhir K. Bowry. (2002). Quo vadis Dialysis Membrane?. Artificial Organs. 26(2). 152–159. 14 indexed citations
13.
Schall, Christian, et al.. (2002). Verification of the chemical composition and specifications of haemodialysis membranes by NMR and GPC-FTIR-coupled spectroscopy. Biomaterials. 23(15). 3131–3140. 8 indexed citations
14.
Eloot, Sunny, et al.. (2002). In Vitro Evaluation of the Hydraulic Permeability of Polysulfone Dialysers. The International Journal of Artificial Organs. 25(3). 210–216. 17 indexed citations
15.
Vienken, Joerg & Claudio Ronco. (2001). New Developments in Hemodialyzers. Contributions to nephrology. 105–118. 7 indexed citations
16.
Czermak, Peter, et al.. (2000). Membranes for Endotoxin Removal from Dialysate: Considerations on Feasibility of Commercial Ceramic Membranes. Artificial Organs. 24(10). 826–829. 15 indexed citations
17.
Matata, Bashir M., S. Sundaram, J.M. Courtney, et al.. (1995). In vitro contact phase activation with haemodialysis membranes: role of pharmaceutical agents. Biomaterials. 16(17). 1305–1312. 12 indexed citations
18.
Bambauer, Rolf, et al.. (1994). Bacteria‐ and Endotoxin‐Free Dialysis Fluid for Use in Chronic Hemodialysis. Artificial Organs. 18(3). 188–192. 16 indexed citations
19.
Diamantoglou, M., Horst‐Dieter Lemke, & Joerg Vienken. (1994). Cellulose-Ester as Membrane Materials for Hemodialysis. The International Journal of Artificial Organs. 17(7). 385–391. 19 indexed citations
20.
Deppisch, Reinhold, et al.. (1990). Assembly of terminal SC5b-9 complement complexes: a new index of blood-membrane interaction.. PubMed. 16(1). 73–6. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026